Suppr超能文献

S-(3,4-二氯苄基)异硫脲盐酸盐和新型结构相关化合物对包括铜绿假单胞菌和洋葱伯克霍尔德菌复合体在内的多重耐药菌的体外活性。

In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.

机构信息

Microbiology Department, Freeman Hospital, Newcastle upon Tyne, UK.

出版信息

Int J Antimicrob Agents. 2012 Jan;39(1):27-32. doi: 10.1016/j.ijantimicag.2011.08.015. Epub 2011 Oct 10.

Abstract

The aim of this study was to establish the antimicrobial activities of S-(3,4-dichlorobenzyl)isothiourea hydrochloride (A22) and a series of structurally related compounds against multidrug-resistant (MDR) bacteria. The minimum inhibitory concentrations (MICs) of 21 compounds were determined against 18 strains of pathogenic bacteria in addition to Pseudomonas aeruginosa (n=19) and Burkholderia cepacia complex (BCC) (n=20) isolated from the sputa of cystic fibrosis patients. Selected compounds were tested against further isolates, including P. aeruginosa (n=100), BCC (n=12) and Stenotrophomonas maltophilia (n=19). The interaction of S-(4-chlorobenzyl)isothiourea hydrochloride (C2) in combination with conventional antimicrobials was examined against 10 P. aeruginosa strains. Selected compounds were also tested against Enterobacteriaceae producing NDM-1 carbapenemase (n=64) and meticillin-resistant Staphylococcus aureus (MRSA) (n=37). Of the 21 compounds, 14 showed antimicrobial activity that was generally more pronounced against Gram-negative bacteria. Against P. aeruginosa, the most active compound was C2 [MIC for 50% of the organisms (MIC(50))=32μg/mL]. This compound was also the most active against BCC, with all isolates inhibited by 64μg/mL. For all ten strains of P. aeruginosa subjected to combination testing with C2 and conventional antimicrobials, a bactericidal effect was achieved with at least one combination. C2 and A22 both showed strong activity [MIC for 90% of the organisms (MIC(90))=4μg/mL] against Enterobacteriaceae that produced NDM-1 carbapenemase. Finally, S-(4-chlorobenzyl)-N-(2,4-dichlorophenyl)isothiourea hydrochloride showed good activity (MIC(90)=8μg/mL) against MRSA. This work establishes the activity of isothiourea derivatives against a broad range of clinically important MDR bacteria.

摘要

本研究旨在确定 S-(3,4-二氯苄基)异硫脲盐酸盐(A22)和一系列结构相关化合物对多药耐药(MDR)细菌的抗菌活性。除了从囊性纤维化患者痰液中分离出的铜绿假单胞菌(n=19)和伯克霍尔德菌复合群(BCC)(n=20)外,还测定了 21 种化合物对 18 种病原菌的最低抑菌浓度(MIC)。选择的化合物进一步针对其他分离株进行了测试,包括铜绿假单胞菌(n=100)、BCC(n=12)和嗜麦芽窄食单胞菌(n=19)。还研究了 S-(4-氯苄基)异硫脲盐酸盐(C2)与常规抗菌药物联合使用对 10 株铜绿假单胞菌的相互作用。还测试了所选化合物对产 NDM-1 碳青霉烯酶的肠杆菌科(n=64)和耐甲氧西林金黄色葡萄球菌(MRSA)(n=37)的抗菌活性。在 21 种化合物中,有 14 种具有抗菌活性,通常对革兰氏阴性菌的活性更强。对铜绿假单胞菌而言,最有效的化合物是 C2[半数抑菌浓度(MIC50)为 32μg/mL]。该化合物对 BCC 的活性也最强,所有分离株均被 64μg/mL 抑制。在对 10 株铜绿假单胞菌进行 C2 与常规抗菌药物联合测试的所有菌株中,至少有一种组合产生了杀菌作用。C2 和 A22 对产 NDM-1 碳青霉烯酶的肠杆菌科均表现出较强的活性[MIC90 为 4μg/mL]。最后,S-(4-氯苄基)-N-(2,4-二氯苯基)异硫脲盐酸盐对 MRSA 表现出良好的活性(MIC90=8μg/mL)。本研究确定了异硫脲衍生物对广泛的临床重要 MDR 细菌的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验